Literature DB >> 193047

Possible feed-back inhibition of noradrenaline release by purine compounds.

M A Enero, B Q Saidman.   

Abstract

The contractile responses to transmural stimulation of, and the overflow of tritium from the rat portal vein prelabelled with 3H-noradrenaline were studied. The contractile responses of the rat portal vein were sustained throughout the period of stimulation. The tension developed did not decline when two consecutive periods of stimulation were compared. In contrast, the tritium overflow decreased during the second period of stimulation. Preincubation with 3 micronM phenoxybenzamine during 30 min increased 3-fold the tritium overflow during stimulation. Phentolamine and phenoxybenzamine were nearly equipotent in reducing the vascular response to stimulation. In contrast, phentolamine was less potent than phenoxybenzamine in increasing the 3H-noradrenaline overflow elicited by stimulation. The results obtained with phentolamine are interpreted in terms of a different potency of phentolamine to produce blockade of prejunctional and postjunctional alpha-adrenoceptors in the rat portal vein. ATP inhibited by 70% the tritium overflow induced by stimulation. The potency of ATP in inhibiting the overflow increased when the prejunction alpha-adrenoceptors were blocked. The purine compounds ATP, ADP, AMP and adenosine were roughly equipotent in inhibiting stimulation-induced tritium overflow. The tritium released by stimulation decreased when uptake and metabolism of adenosine were inhibited. Under physiological conditions, a prejunctional purinergic inhibition of noradrenaline release might be involved in an endogenously mediated negative feed-back regulatory mechanism. It is possible that the purinergic inhibition of the noradrenaline liberation elicited by stimulation plays a physiological role in tissues with both purinergic and adrenergic innervation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 193047     DOI: 10.1007/bf00508808

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  39 in total

1.  Inhibition by dopamine of 3H-noradrenaline release elicited by nerve stimulation in the isolated cat's nictitating membrane.

Authors:  M A Enero; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Effect of drugs on the uptake and metabolism of H3-norepinephrine.

Authors:  G HERTING; J AXELROD; L G WHITBY
Journal:  J Pharmacol Exp Ther       Date:  1961-11       Impact factor: 4.030

3.  Inhibition of acetylcholine release from cholinergic nerves by adenosine, adenine nucleotides and morphine: antagonism by theophylline.

Authors:  J Sawynok; K H Jhamandas
Journal:  J Pharmacol Exp Ther       Date:  1976-05       Impact factor: 4.030

4.  Evidence for prostaglandin mediated prejunctional control of renal sympathetic transmitter release and vascular tone.

Authors:  M H Frame; P Hedqvist
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

5.  Evidence that most noradrenaline is stored without ATP in sympathetic large dense core nerve vesicles.

Authors:  H Lagercrantz; L Stajärne
Journal:  Nature       Date:  1974-06-28       Impact factor: 49.962

Review 6.  Purinergic nerves.

Authors:  G Burnstock
Journal:  Pharmacol Rev       Date:  1972-09       Impact factor: 25.468

7.  Alpha sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart.

Authors:  K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

8.  Correlation between noradrenaline release and effector response to nerve stimulation in rat portal vein in vitro.

Authors:  J Häggendal; B Johansson; J Jonason; B Ljung
Journal:  Acta Physiol Scand Suppl       Date:  1970

9.  [3H]adenosine triphosphate: release during stimulation of enteric nerves.

Authors:  C Su; J A Bevan; G Burnstock
Journal:  Science       Date:  1971-07-23       Impact factor: 47.728

10.  Effect of flow-stop on noradrenaline release from normal spleens and spleens treated with cocaine, phentolamine or phenoxybenzamine.

Authors:  S M Kirpekar; M Puig
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

View more
  34 in total

1.  Pre- and post-junctional effects of adenosine triphosphate on noradrenergic transmission in the rabbit ear artery.

Authors:  H Miyahara; H Suzuki
Journal:  J Physiol       Date:  1987-08       Impact factor: 5.182

2.  Mutual interaction between presynaptic alpha 2-adrenoceptors and 5-HT1B receptors on the sympathetic nerve terminals of the rat inferior vena cava.

Authors:  G J Molderings; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-05       Impact factor: 3.000

3.  Presynaptic alpha 2-adrenoceptor, opioid kappa-receptor and adenosine A1-receptor interactions on noradrenaline release in rabbit brain cortex.

Authors:  N Limberger; L Späth; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-07       Impact factor: 3.000

4.  Inhibition by nucleotides acting at presynaptic P2-receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens.

Authors:  I von Kügelgen; E Schöffel; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

5.  Potentiation of the effects of adenosine on isolated cardiac and smooth muscle by diazepam.

Authors:  A S Clanachan; R J Marshall
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

6.  Inhibition of noradrenaline release by adenosine.

Authors:  A R Wakade; T D Wakade
Journal:  J Physiol       Date:  1978-09       Impact factor: 5.182

7.  Hypertension and enhanced beta-adrenoceptor-mediated facilitation of noradrenaline release produced by chronic blockade of adenosine receptors.

Authors:  S Guimarães; A Albino-Teixeira; M Q Paiva
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

8.  Long-term administration of 1,3-dipropyl-8-sulphophenylxanthine (DPSPX) alters alpha 2-adrenoceptor-mediated effects at the pre- but not at the postjunctional level.

Authors:  S Guimarães; M Q Paiva; D Moura; M J Vaz-da-Silva; A Albino-Teixeira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-12       Impact factor: 3.000

9.  Indirect evidence that purinergic modulation of perivascular adrenergic neurotransmission in the portal vein is a physiological process.

Authors:  G Burnstock; R Crowe; C Kennedy; J Török
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

10.  Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: contribution of P1- and P2-purinoceptors.

Authors:  K Kurz; I von Kügelgen; K Starke
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.